Hyeon Jeong Oh - Concepedia

Author

Hyeon Jeong Oh

Seoul National University ORCID

Also Known As

Ho-Young Lee, Hyeon Jeong Oh, Hyeon Oh Ra, Oh, Hyeon Jeong

Publications

839

Citations

H-Index

Concepts

All Affiliations

Seoul National University Seoul National University Hospital Seoul National University Bundang Hospital SNUH SMG-SNU Boramae Medical Center New Generation University College

About

Hyeon Jeong Oh is an author at Seoul National University specializing in medicine, cancer research, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	256
2	Engineering	1	1	86
3	Biochemistry	1	1	42
4	Biostatistics	1	1	86
5	Gastroenterology	1	1	16

Hyeon Jeong Oh

Publications

766

Citations

H-Index

Page 1

	Year	Citations
Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes Joonho Park, Hyeon Jeong Oh, Dohyun Han, Journal of Proteome Research Proteomic SurrogatesBreast OncologyEngineeringPathologyTumor Biology	2019	86
Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer Hyeon Jeong Oh, Jeong Mo Bae, Xian-Yu Wen, Journal of Pathology and Translational Medicine	2017	64
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Cancer Immunology Immunotherapy DysbiosisMicrosatellite-unstable Colorectal CancersMedicineFusobacterium Nucleatum StatusColorectal Cancer	2020	60
Prognostic Impact of <i>Fusobacterium nucleatum</i> Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy Hyeon Jeong Oh, Jung Ho Kim, Jeong Mo Bae, Journal of Pathology and Translational Medicine	2018	59
p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy Hyeon Jeong Oh, Jeong Mo Bae, Xianyu Wen, British Journal of Cancer	2019	50
Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma Jeong Mo Bae, Jung Ho Kim, Hyeon Jeong Oh, Modern Pathology Metabolic HallmarkTumor BiologyBiochemistryOncogenic AgentMedicine	2016	42
Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients Yonghoon Choi, Nayoung Kim, Ki Wook Kim, World Journal of Gastroenterology	2022	40
Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience Heera Yoen, Hye Eun Park, Se Hyung Kim, Korean Journal of Radiology	2020	38
Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers Jung Ho Kim, Mi-Kyoung Seo, Ji Ae Lee, Journal for ImmunoTherapy of Cancer	2021	35
Prognostic significance of stromal GREM1 expression in colorectal cancer Bo Gun Jang, Hye Sung Kim, Weon Young Chang, Human Pathology Tumor BiologyMedicineColorectal CancerPathologyMolecular Diagnostics	2016	31

Page 1